Interv Akut Kardiol 2010; 9(Suppl.B): 21-24

Percutaneous transluminary pulmonary valvuloplasty isolated valvular pulmonary stenosis in adults

Ján Zelenay, Viliam Fridrich
Národný ústav srdcových a cievnych chorôb, a. s., Oddelenie intervenčnej kardiológie, Bratislava

Aim: The aim of the treatment of isolated valvular pulmonary stenosis is to remove or reduce severe stenosis of the pulmonary valve

without using surgical intervention.

Patients and metods: Our retrospective study involved 30 patients of average age of 41.1 years (mean age 43 years). In 18 women (60 %)

and 12 men (30 %) anatomical, morfological, hemodynamics and functional success of percutaneous transluminal pulmonary valvuloplasty

(PTPV) was evaluated. Following parameters were evaluated: Peak systolic gradient (PSG), index of systolic intraventricular pressures

(ISIVP) and pulmonal valve surface area index (PVSAI).

Result: Before PTPV the average PSG was 95,7 mm Hg. After PTPV PSG was reduced to 38.8mmHg (p < 0.001). The average ISIVP before

intervention was 1.09, after intervention 0.45 (p < 0.001). The average PVSAI was 0.46 cm2/m2. After PTPV an increase to 0.82 cm2/m2. In

long term follow-up 83.3 % patients benefit from the treatment (average functional classification NYHA 2.0).

Conclusion: PTPV is, in the treatment of isolated valvular pulmonary stenosis, the method of the first and most definite choice for very

good therapeutic results, lower costs and lower invasiveness.

Keywords: isolated valvular pulmonary stenosis, percutaneous transluminal pulmonary valvuloplasty

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zelenay J, Fridrich V. Percutaneous transluminary pulmonary valvuloplasty isolated valvular pulmonary stenosis in adults. Interv Akut Kardiol. 2010;9(Suppl.B):21-24.
Download citation

References

  1. Warnes CA, Liberthson R, Danielson GK, et al. Task Force 1: The changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001; 37: 1170-1175. Go to original source... Go to PubMed...
  2. Perloff JK. Congenital heart disease in Adults. In: Braunwald E. Heart disease. Philadelphia: WB Sanders Co., 1992: 966-991.
  3. Zelenay J, Fridrich V, Riečanský I. Perkutánna translúmenová pulmonálna valvuloplastika u dospelých. Lek Obz 2003; 52: 262-265.
  4. Rubio-Alvarez V, Limon Rl, Soni J. Valvulotomias intracardiacas por medio de un catheter. Arch Inst Cardiol Mex 1953; 23: 183-192. Go to PubMed...
  5. Kan JS, White RI, Mitchel SE. Percutaneous balloon valvuloplasty. A new method for treating congenital pulmonary stenosis. N Engl J Med 1982; 9: 540-542. Go to original source... Go to PubMed...
  6. Pepine CJ, Gressner JH, Feldman RL. Percutaneous balloon valvuloplasty. Am J Cardiol 1982; 50: 352. Go to original source... Go to PubMed...
  7. Zelenay J, Fridrich V, Riečanský I. Diagnostika a intervenčná liečba izolovanej chlopňovej pulmonálnej stenózy. Cardiol 2004; 13: 352-358.
  8. Nugent EW, Freedom RM, Nora JJ, Ellison RC, Rowe Rd, Nadas AS. Clinical course in pulmonic stenosis. Circulation 1977; 56(Supp.): 138-147..
  9. Escalera RB, Chase TJ, Owada CY. Triple-balloon pulmonary valvuloplasty. Cath Cardiovasc Interv 2005; 66: 446-451. Go to original source... Go to PubMed...
  10. Poon LK. Pulmonary regurgitation after percutaneous balloon izolated pulmonary valvar stenosis in childhood. Cardiol Zoung 2003; 13: 444-450. Go to original source...
  11. Rao PS. How big a balloon and how many balloons for pulmonary valvuloplasty? Am Heart J. 1988; 116: 577-580. Go to original source... Go to PubMed...
  12. Mc. Crindle BW, Kan JS. Long-term results after balloon pulmonary valvuloplasty. Circulatio 1994; 83: 1915-1922. Go to original source...
  13. Ross-Hesselink JW, Meiboom FJ, Spitaels SE. Long-term outcome at pulmonary stenosis (a longitudinal study of 22-23 years) Eur Heart J 2006; 27: 484. Go to original source... Go to PubMed...
  14. Werinski A, Rudzinski A, Krol-Jawien W, Kuzma J. Percutaneous balloon valvuloplasty for the treatment of pulmonary valve: children - a single centre experience. Kardiol Pol 2009; 67: 369-375. Go to PubMed...
  15. Čerbák R. Doporučené postupy pro diagnostiku a léčbu chlopeních srdečných vad v dospelém veku. In: Doporučené postupy v kardiológii. Brno: Česká kardiologická společnost, 1998: 7-12.
  16. Škvařil J, Jebavý P, Ebrt M, et al. Valvuloplastika pulmonálny chlopne u dospělých. Interv Akut Kardiol 2003; 2: 172-177.
  17. Bonow RO, Carabello B, De Leon AC, et al. ACC/AHA quidelines for the management of patients with valvular heart disease. J Am Cardiol 1998; 32: 1486-1588. Go to original source... Go to PubMed...
  18. Mendelson AM, Benerjee B, Meyer RA, et al. Predictorsof successful pulmonary balloon valvuloplasty. 10-years experience. Cathet Cardiovasc Diagn 1996; 39: 1486-1588. Go to original source...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.